基于系统药理学方法研究四逆散治疗重度抑郁症的作用机制OA
System Pharmacology Reveals How Sinisan Treats Major Depressive Disorder
目的:四逆散是中医经方,具有多成分、多靶点的特性,已显示出潜在的抗抑郁作用;然而,其潜在的分子机制尚未完全阐明.本研究旨在运用系统药理学方法探讨四逆散抗重度抑郁症(MDD)的潜在分子机制.方法:采用系统药理学方法系统鉴定四逆散在重度抑郁症治疗中相关的活性化合物、潜在靶点及生物学通路.构建了成分-靶点网络、疾病相关靶点网络、蛋白质-蛋白质相互作用(PPI)网络,并进行了通路富集分析.进一步进行分子对接分析,以评估代表性活性化合物与核心靶蛋白之间的潜在相互作用.结果:共鉴定出123种生物活性化合物和244个四逆散相关潜在靶点.将四逆散相关靶点与重度抑郁症相关靶点整合后,获得27个重叠治疗靶点.功能富集分析提示,四逆散可能通过多种生物学过程和信号通路发挥抗抑郁作用,包括神经活性配体-受体相互作用、5-羟色胺能突触、色氨酸代谢、药物代谢及甾体激素生物合成.分子对接分析提示核心靶点与四逆散代表性活性化合物之间存在潜在相互作用,为进一步实验验证提供了初步计算证据.结论:本研究从系统层面揭示了四逆散治疗重度抑郁症的潜在机制,提示四逆散可能通过多成分、多靶点的相互作用调控抑郁症相关生物学网络.这些发现为四逆散作为重度抑郁症潜在治疗策略的后续实验验证和转化研究提供了理论基础.
Objective Sinisan(SNS),a classical traditional Chinese medicine formula characterized by multicomponent and multitarget properties,has shown potential antidepressant effects;however,its underlying molecular mechanisms remain incompletely understood.This study aimed to investigate the potential molecular mechanisms of SNS against major depressive disorder(MDD)using a systems pharmacology approach. Methods Network pharmacology was applied to systematically identify the active compounds,potential targets,and biological pathways associated with SNS in MDD treatment.Compound-target networks,disease-related target networks,protein-protein interaction networks,and pathway enrichment analyses were constructed.Molecular docking analysis was further performed to evaluate the potential interactions between representative active compounds and core target proteins. Results A total of 123 bioactive compounds and 244 potential SNS-related targets were identified.By integrating SNS-associated targets with MDD-related targets,27 overlapping therapeutic targets were obtained.Functional enrichment analysis suggested that SNS may exert antidepressant effects through multiple biological processes and signaling pathways,including neuroactive ligand-receptor interaction,serotonergic synapse,tryptophan metabolism,drug metabolism,and steroid hormone biosynthesis.Molecular docking analysis suggested potential interactions between core targets and representative active compounds of SNS,providing preliminary computational evidence for further experimental validation. Conclusion This study provides a systems-level perspective on the potential mechanisms of SNS in MDD and suggests that SNS may regulate depression-related biological networks through multicomponent and multitarget interactions.These findings provide a theoretical basis for future experimental validation and translational research on SNS as a potential therapeutic strategy for MDD.
汪保英;刘辉;谢哲;杨欣雨;许二平;栗俞程;白明
河南中医药大学,河南省豫药全产业链研发协同创新中心,河南郑州||河南中医药大学中医药科学院,河南郑州河南中医药大学,河南省豫药全产业链研发协同创新中心,河南郑州||河南中医药大学药学院,河南郑州河南中医药大学,河南省豫药全产业链研发协同创新中心,河南郑州||河南中医药大学中医药科学院,河南郑州河南中医药大学,河南省豫药全产业链研发协同创新中心,河南郑州||河南中医药大学中医药科学院,河南郑州河南中医药大学,河南省豫药全产业链研发协同创新中心,河南郑州||河南中医药大学中医药科学院,河南郑州河南中医药大学,河南省豫药全产业链研发协同创新中心,河南郑州||河南中医药大学中医药科学院,河南郑州河南中医药大学,河南省豫药全产业链研发协同创新中心,河南郑州||河南中医药大学中医药科学院,河南郑州
重度抑郁症系统药理学方法四逆散方剂多成分多靶点分子对接
major depressive disordersystem pharmacology methodSinisan formulasmulticomponent and multitargetmolecular docking
《中医学报(英文)》 2026 (3)
202-214,中插55-中插67,26
This work was supported by the National Natural Science Foundation of China(82274496). 国家自然科学基金项目(82274496)
评论